Headquarters
855 N WOLFE ST, SUITE 624, BALTIMORE, MD 21205-1511, US
BALTIMORE, MD, US
ELIXIRGEN THERAPEUTICS, INC.
From the company
Elixirgen Therapeutics develops life-changing therapies for rare diseases and aging-associated diseases using its ZSCAN4 and Bobcat® mRNA technologies. Its ZSCAN4 technology is in clinical trials to extend telomeres in patients with Telomere Biology Disorders, and its Bobcat® mRNA technology delivers large payloads such as full-length dystrophin for Duchenne muscular dystrophy.
Products & services offered
Classifications
- Ownership classifications (2)
- Asian-Pacific American Owned, Minority Owned Business
Facilities
Send your requirements
Quantities, certifications, and timing.